Christopher D. Offen
Directeur Général chez Wynden Pharmaceuticals, Inc.
Profil
Christopher D.
Offen is Chief Executive Officer of Wynden Pharmaceuticals, Inc. Previously, he formed Chris Offen & Associates LLC.
He attended the Advanced Executive Program at the Kellogg School of Business, Northwestern University.
Mr. Offen received an MBA from George Mason concentrating in Marketing and Management.
Postes actifs de Christopher D. Offen
| Sociétés | Poste | Début |
|---|---|---|
Wynden Pharmaceuticals, Inc.
 Wynden Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wynden Pharmaceuticals, Inc. provides pharmaceutical preparations. Its services include research, oncology and cardiovascular disease, and drug development. The company is headquartered in Alpharetta, GA. | Directeur Général | - |
Formation de Christopher D. Offen
| George Mason University | Masters Business Admin |
| The Catholic University of America | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Wynden Pharmaceuticals, Inc.
Wynden Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wynden Pharmaceuticals, Inc. provides pharmaceutical preparations. Its services include research, oncology and cardiovascular disease, and drug development. The company is headquartered in Alpharetta, GA. | Health Technology |
